Calculation
| P/OP | = | Share price1, 2, 3 | ÷ | Operating profit per share1 | Operating profit per share1 | = | Operating income1 (in millions) |
÷ | No. shares of common stock outstanding2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 11, 2022 | 36.77 | = | 251.65 | ÷ | 6.84 | 6.84 | = | 2,584 | ÷ | 377,544,686 | |
| Feb 11, 2021 | 41.52 | = | 245.34 | ÷ | 5.91 | 5.91 | = | 2,223 | ÷ | 376,200,942 | |
| Feb 6, 2020 | 30.13 | = | 218.24 | ÷ | 7.24 | 7.24 | = | 2,713 | ÷ | 374,575,145 | |
| Feb 7, 2019 | 26.55 | = | 180.75 | ÷ | 6.81 | 6.81 | = | 2,537 | ÷ | 372,664,636 | |
| Feb 8, 2018 | 24.21 | = | 148.01 | ÷ | 6.11 | 6.11 | = | 2,290 | ÷ | 374,642,060 | |
| Feb 9, 2017 | 21.23 | = | 123.32 | ÷ | 5.81 | 5.81 | = | 2,166 | ÷ | 372,878,298 | |
| Feb 11, 2016 | 19.27 | = | 96.16 | ÷ | 4.99 | 4.99 | = | 1,861 | ÷ | 372,982,213 | |
| Feb 12, 2015 | 28.38 | = | 93.37 | ÷ | 3.29 | 3.29 | = | 1,246 | ÷ | 378,749,951 | |
| Feb 13, 2014 | 24.90 | = | 82.75 | ÷ | 3.32 | 3.32 | = | 1,256 | ÷ | 377,870,936 | |
| Feb 27, 2013 | 13.91 | = | 63.66 | ÷ | 4.58 | 4.58 | = | 1,741 | ÷ | 380,512,172 | |
| Feb 13, 2012 | 12.17 | = | 53.87 | ÷ | 4.42 | 4.42 | = | 1,686 | ÷ | 381,020,353 | |
| Feb 18, 2011 | 14.07 | = | 63.00 | ÷ | 4.48 | 4.48 | = | 1,751 | ÷ | 391,246,163 | |
| Feb 26, 2010 | 13.26 | = | 53.10 | ÷ | 4.01 | 4.01 | = | 1,594 | ÷ | 398,051,370 | |
| Feb 20, 2009 | 10.45 | = | 40.03 | ÷ | 3.83 | 3.83 | = | 1,519 | ÷ | 396,531,769 | |
| Feb 28, 2008 | 20.77 | = | 66.04 | ÷ | 3.18 | 3.18 | = | 1,307 | ÷ | 411,183,514 | |
| Feb 28, 2007 | 23.58 | = | 62.02 | ÷ | 2.63 | 2.63 | = | 1,074 | ÷ | 408,450,841 | |
| Mar 7, 2006 | 18.61 | = | 45.81 | ÷ | 2.46 | 2.46 | = | 999 | ÷ | 405,842,341 |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Stryker Corp. Annual Report.
The financial trajectory from 2006 to 2022 is characterized by substantial growth in share price and operating profitability, accompanied by significant fluctuations in the Price to Operating Profit (P/OP) valuation multiple.
- Share Price Performance
- A long-term upward trend is observed, with the share price increasing from 45.81 in 2006 to 251.65 by 2022. While the overall progression was positive, notable volatility occurred between 2009 and 2012, followed by a period of accelerated appreciation beginning in 2016.
- Operating Profitability Trends
- Operating profit per share demonstrated a general increase, rising from 2.46 to 6.84 over the analyzed period. This growth was not linear; temporary contractions occurred in 2014 and 2015, where profit per share declined to approximately 3.30, and again in 2021, when it fell to 5.91 before recovering in 2022.
- P/OP Ratio Dynamics
- The P/OP ratio reflects shifting market valuations across three distinct phases. A period of valuation compression is evident between 2009 and 2013, with the ratio reaching a low of 10.45 in 2009. A subsequent expansion phase began in 2014, with the ratio climbing from 24.90 to 30.13 by 2020. Valuation reached a peak in 2021 at 41.52, representing a significant premium over historical norms, before moderating to 36.77 in 2022.
The divergence between operating profit growth and share price growth became most pronounced in the latter part of the period. The sharp increase in the P/OP ratio since 2014 indicates that the market valuation expanded at a rate exceeding the growth of underlying operating profits, suggesting an increase in the multiple investors were willing to pay for each dollar of operating profit.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Comparison to Competitors
| Stryker Corp. | Abbott Laboratories | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
|---|---|---|---|---|---|
| Feb 11, 2022 | 36.77 | 24.45 | 56.11 | 37.44 | 18.77 |
| Feb 11, 2021 | 41.52 | 40.69 | 88.37 | 26.29 | 14.12 |
| Feb 6, 2020 | 30.13 | 34.03 | 48.89 | 21.26 | 14.40 |
| Feb 7, 2019 | 26.55 | 36.64 | 49.87 | 17.64 | 14.58 |
| Feb 8, 2018 | 24.21 | 60.88 | 44.40 | 22.64 | 14.42 |
| Feb 9, 2017 | 21.23 | 24.25 | 28.93 | 22.18 | 11.79 |
| Feb 11, 2016 | 19.27 | 19.80 | 27.25 | 28.81 | 9.59 |
| Feb 12, 2015 | 28.38 | 27.50 | 34.42 | 16.68 | 10.12 |
| Feb 13, 2014 | 24.90 | 22.79 | 17.96 | 11.80 | 7.22 |
| Feb 27, 2013 | 13.91 | 6.82 | 26.21 | — | 6.32 |
| Feb 13, 2012 | 12.17 | 15.35 | 27.83 | — | 6.55 |
| Feb 18, 2011 | 14.07 | 11.92 | 23.28 | — | 5.90 |
| Feb 26, 2010 | 13.26 | 13.54 | 33.47 | — | 5.95 |
| Feb 20, 2009 | 10.45 | 14.66 | 14.45 | — | 6.59 |
| Feb 28, 2008 | 20.77 | 18.76 | 55.84 | — | 7.62 |
| Feb 28, 2007 | 23.58 | 40.49 | 38.98 | — | 10.47 |
| Mar 7, 2006 | 18.61 | 15.48 | 50.21 | — | 14.87 |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).